Intrinsic Value of S&P & Nasdaq Contact Us

Iterum Therapeutics plc ITRM NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IE • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Iterum Therapeutics plc (ITRM) has 17 known insider and institutional holders on record. The largest holder is Sofinnova Venture Partners IX, L.P. with 1,626,514 shares. Other notable holders include Kelly David George and Frazier Healthcare VII, L.P..

Over the last 12 months, insiders have made 4 transactions in ITRM stock — 3 buys (valued at $207.05K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ITRM Insider Ownership

Top Holder
Sofinnova Venture Partners IX, L.P.
1,626,514 shares
Buys (12 mo)
3
$207.05K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 75%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Sofinnova Venture Partners Ix, L.p. 10 Percent Owner 1,626,514 2020-06-03
100%
2 Kelly David George Director 647,059 2022-06-17
40%
3 Frazier Healthcare Vii, L.p. 10 Percent Owner 333,000 2020-01-23
20%
4 Dunne Michael W. Director 241,001 2025-11-20
15%
5 Chin Mark Director 237,795 2022-06-17
15%
6 Hecht Beth Director 237,795 2022-06-17
15%
7 Coyne Christine Chief Commercial Officer 200,000 2025-07-03
12%
8 Matthews Judith M. Chief Financial Officer 100,000 2023-04-03
6%
9 Fishman Corey N. Chief Executive Officer 54,449 2023-11-20
3%
10 Ahrens Brenton Karl Director 29,125 2022-12-28
2%
11 Edick Paul R Director 25,236 2018-08-27
2%
12 Malik Shahzad Director 19,671 2019-06-17
1%
13 Puttagunta Sailaja Chief Medical Officer 10,369 2023-12-04
1%
14 Schaffnit Jeffrey R. Chief Commercial Officer 6,365 2018-05-29
0%
15 Healy James 10 Percent Owner 5,703 2019-06-17
0%
16 Hunt Ronald Director 5,479 2022-12-28
0%
17 Heron Patrick J 10 Percent Owner 2,852 2019-06-17
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-11-18 Dunne Michael W. Director Informative Buy 6,000 $0.37 $2.19K
2025-08-08 Dunne Michael W. Director Informative Buy 15,000 $0.72 $10.85K
2025-07-01 Coyne Christine Chief Commercial Officer RSU Award 200,000 $0.97 $194K
2025-07-01 Coyne Christine Officer Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message